We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Accept Cookies
Plasma and serum viscosity measurements have an important role in the clinical management of patients prone to hyperviscosity syndrome. Hyperviscosity syndrome can occur in association with a variety of clinical diagnoses, such as polycythemia, Waldenström macroglobulinemia, multiple myeloma, and leukemia. The viscosity at which symptoms develop is variable, but they rarely appear below a serum or plasma viscosity of 3 cP. Therefore, accurate measurement of serum or plasma viscosity is an important component of patient management.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy